Concord Medical Co., Ltd. (TPEX:6518)

Concord Medical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	128.93	125.18	109.75	111.26	246.91	198.8
Short-Term Investments	97	158	211.5	209	100	-
Cash & Short-Term Investments	225.93	283.18	321.25	320.26	346.91	198.8
Cash Growth	-26.08%	-11.85%	0.31%	-7.68%	74.50%	234.55%
Accounts Receivable	313.13	303.15	301.6	306.75	314.22	310.82
Other Receivables	0.71	0.2	-	3.13	7.62	9.6
Receivables	313.84	303.34	301.6	309.88	321.85	320.42
Inventory	17.05	9.36	3.98	2.56	6.19	9.37
Prepaid Expenses	4.45	5.95	4.17	5.64	3.21	2.93
Other Current Assets	-	-	-	-	-	2.77
Total Current Assets	561.27	601.83	631	638.34	678.17	534.29
Property, Plant & Equipment	110.38	136.82	149.82	136.64	117.75	526.83
Long-Term Investments	130.63	114.93	20	-	-	-
Goodwill	7.31	7.31	-	-	-	-
Other Intangible Assets	12.67	13.77	2.65	2.63	1.95	1.76
Long-Term Accounts Receivable	10.45	4.64	3.34	4.63	0.96	-
Long-Term Deferred Tax Assets	4.26	4.72	0.26	0.29	0.54	0.4
Other Long-Term Assets	382.06	336.57	356.74	369.13	375.84	18.73
Total Assets	1,219	1,221	1,164	1,152	1,176	1,083

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	244.14	245.24	235.04	230.72	245.86	228.03
Accrued Expenses	-	-	-	0.28	-	-
Short-Term Debt	26.59	25.85	-	-	-	-
Current Portion of Leases	31.33	30.2	25.41	23.05	20.49	18.48
Current Income Taxes Payable	6.64	8.53	7.43	4.68	9.74	5.52
Current Unearned Revenue	0.85	0.1	-	0.04	2.21	0.04
Other Current Liabilities	29.2	27.4	17.65	23.78	20.43	16.7
Total Current Liabilities	338.75	337.32	285.53	282.54	298.72	268.77
Long-Term Debt	-	-	35	35	-	-
Long-Term Leases	122.02	122.37	141.46	148.63	160.43	171.68
Long-Term Deferred Tax Liabilities	2.12	2.24	-	-	-	-
Other Long-Term Liabilities	4.52	4.52	4.54	4.54	4.91	4.8
Total Liabilities	467.41	466.45	466.53	470.71	464.06	445.25

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	333.33	333.33	333.33	333.33	333.33	333.33
Additional Paid-In Capital	179.22	179.22	179.22	179.22	179.22	179.22
Retained Earnings	212.78	215.41	184.71	169.23	159.82	125.83
Comprehensive Income & Other	-	-	-	-0.75	-0.75	-0.75
Total Common Equity	725.33	727.96	697.26	681.03	671.62	637.63
Minority Interest	26.29	26.17	-	-	39.98	-
Shareholders' Equity	751.62	754.13	697.26	681.03	711.6	637.63
Total Liabilities & Equity	1,219	1,221	1,164	1,152	1,176	1,083

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	179.94	178.42	201.87	206.68	180.92	190.16
Net Cash (Debt)	45.99	104.76	119.37	113.58	165.99	8.64
Net Cash Growth	-35.44%	-12.24%	5.10%	-31.57%	1822.12%	-
Net Cash Per Share	1.37	3.13	3.57	3.40	4.97	0.34
Filing Date Shares Outstanding	33.33	33.33	33.33	33.33	33.33	33.33
Total Common Shares Outstanding	33.33	33.33	33.33	33.33	33.33	33.33
Working Capital	222.52	264.51	345.47	355.8	379.45	265.52
Book Value Per Share	21.76	21.84	20.92	20.43	20.15	19.13
Tangible Book Value	705.35	706.89	694.62	678.39	669.67	635.86
Tangible Book Value Per Share	21.16	21.21	20.84	20.35	20.09	19.08
Land	-	-	-	-	-	169.14
Buildings	-	-	-	-	-	49.02
Machinery	224.87	261.32	284.31	237.56	205.29	273.95
Construction In Progress	-	-	1.38	3.6	2.71	0.96
Leasehold Improvements	41.45	47.99	48.32	55.47	73.3	86.73

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 8, 2026

Data Sources Report a data error